Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Intravenous Lidocaine Infusion in Lung Cancer Surgery
ChiCTR2200066615Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in bronchial carcinoma (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Overall survival and Disease-free survival. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2200066615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066615.